Abstract
Severe Acute Respiratory Syndrome (SARS-CoV-2) causes the coronavirus disease (COVID-19), which is characterised by severe respiratory syndrome and other complications. It is a serious threat to global public health if proper vaccination is not followed. The efficient COVID-19 management requires vaccination along with other precautionary measures. Public transmission of COVID-19 seems to have decreased and immune response to viral infections has improved by vaccination. The present review discusses in detail about the current situation of the COVID-19, based on the latest reports about approved vaccine types and their efficacy, vaccination status, and various SARS-CoV-2 variants. This review also includes insights into the post-COVID complications in recovered patients. Besides, some of the ill-effects of drugs in inducing other diseases in COVID-19 recovered patients, are also discussed in this review article. This study will help the researchers to prepare strategies for further research on vaccine production and prevent the occurrence of the disease in future.
Publisher
Journal of Pure and Applied Microbiology
Reference89 articles.
1. 1. Han X, Xu P, Ye Q. Analysis of COVID-19 vaccines: Types, thoughts, and application. J Clin Lab Anal. 2021;35(9):e23937. doi: 10.1002/jcla.23937
2. 2. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020;24:91-98. doi: 10.1016/j.jare.2020.03.005
3. 3. Motamedi H, Ari MM, Dashtbin S, et al. An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages. Int Immunopharmacol. 2021;96:107763. doi: 10.1016/j.intimp.2021.107763
4. 4. COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet. 2022 Apr 16;399(10334):1513-1536. doi: 10.1016/S0140-6736(21)02796-3. Epub 2022 Mar 10. Erratum in: Lancet. 2022 Apr 16;399(10334):1468. doi: 10.1016/S0140-6736(22)00621-3
5. 5. World Health Organization. Draft landscape of COVID-19 candidate vaccines. www.who.int. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines. Accessed date, 30 March 2023